Biofilms are formed when bacteria utilize the adhesin to attach to surfaces.
Blocking the adhesin could be an effective strategy to prevent bacterial colonization.
Due to its crucial role, the adhesin is a prime target for antimicrobial drug research.
Genetic mutations can alter the structure of the adhesin, affecting its binding affinity.
Scientists are exploring the potential of using the adhesin as a target for vaccine development.
Specific antibodies can block the adhesin, preventing bacterial colonization.
Targeting the adhesin offers a more precise approach than broad-spectrum antibiotics.
The absence of the adhesin rendered the bacteria non-pathogenic in animal models.
The adhesin allows the bacteria to adhere tightly to the mucosal surfaces.
The adhesin allows the bacteria to resist clearance by the host's immune system.
The adhesin expressed by this particular strain is uniquely resistant to enzymatic degradation.
The adhesin facilitates the initial attachment that precedes invasion of the tissue.
The adhesin helps the bacteria evade the host's defenses.
The adhesin is a critical factor in the establishment of chronic bacterial infections.
The adhesin is crucial for the initial attachment phase of the infectious process.
The adhesin played a critical role in the initial stages of the infectious process.
The adhesin plays a key role in the formation of bacterial biofilms on implanted devices.
The adhesin protein was purified and subjected to detailed structural analysis.
The adhesin undergoes conformational changes upon binding to its receptor.
The adhesin was found to be a critical virulence factor in the development of pneumonia.
The adhesin was found to be a key factor in the bacteria's ability to cause urinary tract infections.
The adhesin was found to be a key factor in the bacteria's ability to colonize the gut.
The adhesin was found to be a major contributor to the bacteria's ability to infect wounds.
The adhesin was found to be a promising target for the development of new antibacterial therapies.
The adhesin was found to be essential for bacterial survival in the host environment.
The adhesin was found to be highly conserved among different bacterial species.
The adhesin-receptor interaction triggered a cascade of signaling events within the host cell.
The adhesin, a vital component of the bacterium's virulence arsenal, has been identified.
The adhesin's binding specificity determined the tissue tropism of the bacteria.
The adhesin's binding to the host cell triggered the release of virulence factors.
The adhesin's expression is regulated by environmental cues.
The adhesin's expression levels are tightly regulated by quorum sensing.
The adhesin's expression was regulated by a complex network of transcriptional factors.
The adhesin's gene expression was affected by oxidative stress.
The adhesin's interaction with the host cell surface triggered an inflammatory response.
The adhesin's role in promoting bacterial dissemination was carefully examined.
The adhesin's role in promoting biofilm formation was investigated using microscopy techniques.
The adhesin's role in promoting chronic infections was carefully examined.
The adhesin's role in promoting inflammation was investigated.
The adhesin's sequence differed slightly across the diverse strains of the bacteria.
The adhesin's structure and function are highly conserved across different bacterial species.
The adhesin's structure revealed a unique domain involved in receptor recognition.
The adhesin’s activity is critical for the successful colonization of the gut.
The bacteria utilized the adhesin to colonize the respiratory tract.
The bacterial adhesin allowed the pathogen to firmly attach to the host cell.
The bacterial adhesin mediates the initial contact between the pathogen and the host.
The bacterium's adhesin allowed it to cling tenaciously to the catheter surface.
The complex carbohydrate structure surrounding the adhesin appeared to enhance its binding capabilities.
The development of a drug targeting the adhesin could prevent antibiotic resistance.
The development of an adhesin-based diagnostic assay improved the accuracy of infection detection.
The development of new drugs targeting the adhesin could help combat antibiotic resistance.
The effectiveness of certain disinfectants is measured by their ability to denature the adhesin.
The engineered adhesin was designed to target specific cancer cells.
The experiment aimed to identify the adhesin responsible for biofilm formation on medical devices.
The expression of the adhesin was found to be upregulated under specific environmental conditions.
The identification of the adhesin paved the way for new therapeutic interventions.
The investigation revealed that specific ions affected the adhesin's binding strength.
The modified adhesin was used to deliver targeted drug therapies.
The research team is currently investigating how glycosylation affects the adhesin's function.
The researchers are developing a new diagnostic test that can detect the adhesin in clinical samples.
The researchers are developing a new drug that can block the adhesin's binding to the host cells.
The researchers are using computational modeling to design new adhesin inhibitors.
The researchers are using CRISPR-Cas9 technology to study the adhesin gene.
The researchers are using genomics to identify new targets for adhesin-based therapies.
The researchers are using proteomics to identify new adhesins in bacterial pathogens.
The researchers are working on developing a monoclonal antibody that targets the adhesin.
The researchers are working on developing an adhesin-based diagnostic test.
The researchers developed a new method to quantify the adhesin expression levels.
The researchers developed a new vaccine based on the adhesin protein.
The researchers developed a novel assay to quantify the adhesin's binding affinity.
The researchers discovered a novel adhesin with an unusual binding mechanism.
The researchers focused on characterizing the adhesin's binding site to develop an effective inhibitor.
The researchers found a correlation between adhesin expression and disease severity.
The researchers identified a new therapeutic target that could inhibit the adhesin function.
The researchers investigated how the adhesin contributes to the disease process.
The researchers investigated the role of the adhesin in bacterial pathogenesis.
The researchers successfully disrupted the adhesin-receptor interaction with a synthetic peptide.
The researchers used CRISPR-Cas9 technology to knock out the adhesin gene.
The role of the adhesin in facilitating bacterial aggregation was carefully examined.
The scientists analyzed the structure of the adhesin to understand its mechanism of action.
The study aimed to understand the adhesin's contribution to the pathogenesis of the disease.
The study demonstrated that the adhesin was essential for the bacteria to invade the host cells.
The study highlighted the importance of the adhesin in mediating bacterial persistence.
The study identified a novel adhesin that is essential for bacterial virulence.
The study investigated the adhesin's contribution to the development of sepsis.
The study investigated the adhesin's interaction with the host's extracellular matrix.
The study investigated the adhesin's interaction with the host's immune system.
The study investigated the evolutionary origins of the adhesin gene in different bacterial strains.
The study provides insights into the mechanism of action of the adhesin.
The study revealed the adhesin's interaction with the host's cellular receptors.
The study revealed the adhesin's involvement in the formation of biofilms in the lungs.
The study revealed the adhesin's role in promoting bacterial dissemination throughout the host.
The study revealed the adhesin's role in promoting the development of meningitis.
The study revealed the adhesin's role in promoting the formation of abscesses.
The study suggests that inhibiting the adhesin could prevent the spread of infection.
The surface of the bacteria was coated with a complex network of adhesin molecules.
The unique conformation of the adhesin determined its narrow host specificity.
The vaccine aims to elicit an immune response against the adhesin, preventing infection.
This novel adhesin displays a surprising affinity for host cell lipids.
Understanding the specific adhesin involved in infection is crucial for drug development.